Report overview
There are no?medications?that treat the core symptoms of ASD. Some medications treat co-occurring symptoms that can help people with ASD function better. For example, medication might help manage high energy levels, inability to focus, or self-harming behavior, such as head banging or hand biting. Medication can also help manage co-occurring psychological conditions, such as anxiety or depression, in addition to medical conditions such as seizures, sleep problems, or stomach or other gastrointestinal problems.
This report contains market size and forecasts of Autism Spectrum Disorder Treatment in Global, including the following market information:
Global Autism Spectrum Disorder Treatment Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Autism Spectrum Disorder Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Antipsychotic Drugs Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Autism Spectrum Disorder Treatment include Curemark, LLC, Alembic Pharmaceuticals Limited, Yamo Pharmaceuticals, F. Hoffmann-La Roche Ltd, Aurobindo Pharma Ltd, Otsuka Holdings Co.Ltd, Janssen Pharmaceuticals, Inc, Teva Pharmaceutical Industries Ltd and H.Lundbeck A/S, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autism Spectrum Disorder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autism Spectrum Disorder Treatment Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Autism Spectrum Disorder Treatment Market Segment Percentages, by Type, 2022 (%)
Antipsychotic Drugs
SSRIs/Antidepressants
Stimulants
Sleep Medications
Others
Global Autism Spectrum Disorder Treatment Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Autism Spectrum Disorder Treatment Market Segment Percentages, by Application, 2022 (%)
Autistic Disorder
Asperger's Syndrome
Pervasive Developmental Disorder (PDD)
Others
Global Autism Spectrum Disorder Treatment Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Autism Spectrum Disorder Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autism Spectrum Disorder Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Autism Spectrum Disorder Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Curemark, LLC
Alembic Pharmaceuticals Limited
Yamo Pharmaceuticals
F. Hoffmann-La Roche Ltd
Aurobindo Pharma Ltd
Otsuka Holdings Co.Ltd
Janssen Pharmaceuticals, Inc
Teva Pharmaceutical Industries Ltd
H.Lundbeck A/S
